+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Next-Generation Sequencing Sample Preparation Market by Workflow, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5470903
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Next-Generation Sequencing Sample Preparation Market grew from USD 4.89 billion in 2023 to USD 5.63 billion in 2024. It is expected to continue growing at a CAGR of 15.08%, reaching USD 13.09 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation is a critical component in the genomics landscape, involving processes like DNA/RNA extraction, library preparation, and target enrichment to ensure high-quality sequencing outcomes. These preparatory stages are crucial for generating accurate and comprehensive sequencing data in research and clinical diagnostics. The necessity of NGS sample preparation lies in its ability to standardize sample inputs and enhance the overall efficiency and accuracy of NGS technologies, thereby addressing the growing demand for personalized medicine, genetic disorder understanding, and cancer genomics. The application of NGS spans various fields such as pharmacogenomics, epigenomics, and metagenomics, with notable end-use sectors including academic research institutions, biotechnology firms, and clinical laboratories. Growth factors influencing this market include rapid technological advancements in automation and miniaturization, increasing prevalence of genetic diseases, and the pursuit of precision medicine. Furthermore, robust investment in genomic research and development, along with expanding collaborations between companies and academic institutions, present substantial opportunities for market expansion. However, challenges such as high initial setup costs, complex workflows, and the requirement for sophisticated technical expertise may hinder market penetration, especially in underdeveloped regions. Moreover, factors like data privacy issues and stringent regulatory frameworks could also pose significant barriers. To maximize growth potential, businesses should focus on innovative areas like cost-effective and faster preparation solutions, integration of AI for data analysis, and development of universal preparation kits to simplify workflows. Companies can also benefit from targeting emerging markets and participating in strategic partnerships to foster technology transfer and localization. Given the competitive nature of this market, staying ahead requires a keen focus on ongoing R&D efforts, customizing offerings to meet specific user demands, and expanding the application range of NGS technologies across diverse industrial sectors.

Understanding Market Dynamics in the Next-Generation Sequencing Sample Preparation Market

The Next-Generation Sequencing Sample Preparation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing automation in NGS sample preparation
    • Government & private organizations support for large-scale sequencing
    • Improved reimbursement outline for NGS-based diagnostic tests
  • Market Restraints
    • Ethical concerns associated with NGS sample
  • Market Opportunities
    • Widening application of NGS in agriculture
    • New technological advancements in next-generation sequencing sample preparation
  • Market Challenges
    • Limitations in accurate NGS sample preparation

Exploring Porter’s Five Forces for the Next-Generation Sequencing Sample Preparation Market

Porter’s Five Forces framework further strengthens the insights of the Next-Generation Sequencing Sample Preparation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Next-Generation Sequencing Sample Preparation Market

External macro-environmental factors deeply influence the performance of the Next-Generation Sequencing Sample Preparation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Next-Generation Sequencing Sample Preparation Market

The Next-Generation Sequencing Sample Preparation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Next-Generation Sequencing Sample Preparation Market

The Next-Generation Sequencing Sample Preparation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Next-Generation Sequencing Sample Preparation Market

The Next-Generation Sequencing Sample Preparation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Sequencing Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc., Illumina, Inc., Life Technologies Corp., Macrogen, Inc., Pacific Biosciences of California, Inc., Perkin Elmer, Inc., PierianDx, Inc., Qiagen, Quest Diagnostics Incorporated, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Sequencing Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Workflow
    • Automated Library Preparation
    • Clonal Amplification
    • NGS Library Preparation Kits
    • Semi-Automated Library Preparation
  • Application
    • Agrigenomics & Forensics
    • Clinical Investigation
    • Consumer Genomics
    • HLA Typing/Immune System Monitoring
    • Metagenomics, Epidemiology & Drug Development
    • Oncology
    • Reproductive Health
  • End User
    • Academic Research
    • Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Next-Generation Sequencing Sample Preparation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing automation in NGS sample preparation
5.1.1.2. Government & private organizations support for large-scale sequencing
5.1.1.3. Improved reimbursement outline for NGS-based diagnostic tests
5.1.2. Restraints
5.1.2.1. Ethical concerns associated with NGS sample
5.1.3. Opportunities
5.1.3.1. Widening application of NGS in agriculture
5.1.3.2. New technological advancements in next-generation sequencing sample preparation
5.1.4. Challenges
5.1.4.1. Limitations in accurate NGS sample preparation
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Next-Generation Sequencing Sample Preparation Market, by Workflow
6.1. Introduction
6.2. Automated Library Preparation
6.3. Clonal Amplification
6.4. NGS Library Preparation Kits
6.5. Semi-Automated Library Preparation
7. Next-Generation Sequencing Sample Preparation Market, by Application
7.1. Introduction
7.2. Agrigenomics & Forensics
7.3. Clinical Investigation
7.4. Consumer Genomics
7.5. HLA Typing/Immune System Monitoring
7.6. Metagenomics, Epidemiology & Drug Development
7.7. Oncology
7.8. Reproductive Health
8. Next-Generation Sequencing Sample Preparation Market, by End User
8.1. Introduction
8.2. Academic Research
8.3. Clinical Research
8.4. Hospitals & Clinics
8.5. Pharma & Biotech Entities
9. Americas Next-Generation Sequencing Sample Preparation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Next-Generation Sequencing Sample Preparation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Next-Generation Sequencing Sample Preparation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Agilent Technologies, Inc.
13.1.2. BGI
13.1.3. Bio-Rad Laboratories, Inc.
13.1.4. Eurofins Scientific SE
13.1.5. F. Hoffmann-La Roche Ltd.
13.1.6. Foundation Medicine, Inc.
13.1.7. Illumina, Inc.
13.1.8. Life Technologies Corp.
13.1.9. Macrogen, Inc.
13.1.10. Pacific Biosciences of California, Inc.
13.1.11. Perkin Elmer, Inc.
13.1.12. PierianDx, Inc.
13.1.13. Qiagen
13.1.14. Quest Diagnostics Incorporated
13.1.15. Thermo Fisher Scientific, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET RESEARCH PROCESS
FIGURE 2. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
FIGURE 3. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET DYNAMICS
FIGURE 7. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 8. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 6. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLONAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SEMI-AUTOMATED LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HLA TYPING/IMMUNE SYSTEM MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 34. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 37. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 51. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 54. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 60. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 78. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 88. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 91. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 94. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 97. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 100. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 106. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 115. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 118. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 121. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 133. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 142. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 151. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 152. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Next-Generation Sequencing Sample Preparation Market, which are profiled in this report, include:
  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine, Inc.
  • Illumina, Inc.
  • Life Technologies Corp.
  • Macrogen, Inc.
  • Pacific Biosciences of California, Inc.
  • Perkin Elmer, Inc.
  • PierianDx, Inc.
  • Qiagen
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information